Duvelisib OverviewDuvelisib (INN, previously known as IPI-145) is a dual inhibitor of PI3Kδ and PI3Kγ, in development as a treatment for hematologic malignancies as well as a broad range of inflammatory conditions. The phosphoinositide 3-kinases are involved in cell proliferation and differentiation and have significant potential in hematology fields and inflammatory disease treatments. Ibrutinib and acalabrutinib are other i...
Read more Duvelisib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Duvelisib
Recent Duvelisib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 15mg, 25mg
Other drugs which contain Duvelisib or a similar ingredient: (1 result)
- COPIKTRA Duvelisib